Defining genetic risk factors for scleroderma-associated interstitial lung diseaseIRF5 and STAT4 gene variants are associated with scleroderma while STAT4 is protective against scleroderma-associated interstitial lung disease

被引:0
|
作者
Carmel J. W. Stock
Angelo De Lauretis
Dina Visca
Cecile Daccord
Maria Kokosi
Vasilis Kouranos
George Margaritopoulos
Peter M. George
Philip L. Molyneaux
Svetlana Nihtyanova
Felix Chua
Toby M. Maher
Voon Ong
David J. Abraham
Christopher P. Denton
Athol U. Wells
Louise V. Wain
Elisabetta A. Renzoni
机构
[1] Royal Brompton and Harefield NHS Foundation Trust,Interstitial Lung Disease Unit, National Heart and Lung Institute, Imperial College London
[2] Ospedale Guido Salvini,Unita’ Operativa Malattie Respiratorie
[3] Istituti Clinici Scientifici Maugeri,Division of Pulmonary Rehabilitation
[4] IRCCS,Division of Respiratory Medicine
[5] Lausanne University Hospital (CHUV),Centre for Rheumatology and Connective Tissue Diseases
[6] Royal Free and University College Medical School,Department of Health Sciences
[7] University of Leicester,National Institute for Health Research
[8] Leicester Respiratory Biomedical Research Centre,undefined
[9] Glenfield Hospital,undefined
来源
Clinical Rheumatology | 2020年 / 39卷
关键词
Genetic association; Genetics; SSc-ILD;
D O I
暂无
中图分类号
学科分类号
摘要
Although several genetic associations with scleroderma (SSc) are defined, very little is known on genetic susceptibility to SSc-associated interstitial lung disease (SSc-ILD). A number of common polymorphisms have been associated with SSc-ILD, but most have not been replicated in separate populations. Four SNPs in IRF5, and one in each of STAT4, CD226 and IRAK1, selected as having been previously the most consistently associated with SSc-ILD, were genotyped in 612 SSc patients, of European descent, of whom 394 had ILD. The control population (n = 503) comprised individuals of European descent from the 1000 Genomes Project. After Bonferroni correction, two of the IRF5 SNPs, rs2004640 (OR (95% CI)1.30 (1.10–1.54), pcorr = 0.015) and rs10488631 (OR 1.48 (1.14–1.92), pcorr = 0.022), and the STAT4 SNP rs7574865 (OR 1.43 (1.18–1.73), pcorr = 0.0015) were significantly associated with SSc compared with controls. However, none of the SNPs were significantly different between patients with SSc-ILD and controls. Two SNPs in IRF5, rs10488631 (OR 1.72 (1.24–2.39), pcorr = 0.0098), and rs2004640 (OR 1.39 (1.11–1.75), pcorr = 0.03), showed a significant difference in allele frequency between controls and patients without ILD, as did STAT4 rs7574865 (OR 1.86 (1.45–2.38), pcorr = 6.6 × 10−6). A significant difference between SSc with and without ILD was only observed for STAT4 rs7574865, being less frequent in patients with ILD (OR 0.66 (0.51–0.85), pcorr = 0.0084). In conclusion, IRF5 rs2004640 and rs10488631, and STAT4 rs7574865 were significantly associated with SSc as a whole. Only STAT4 rs7574865 showed a significant difference in allele frequency in SSc-ILD, with the T allele being protective against ILD.Key points• We confirm the associations of the IRF5 SNPs rs2004640 and rs10488631, and the STAT4 SNP rs7574865, with SSc as a whole.• None of the tested SNPs were risk factors for SSc-ILD specifically.• The STAT4 rs7574865 T allele was protective against the development of lung fibrosis in SSc patients.• Further work is required to understand the genetic basis of lung fibrosis in association with scleroderma.
引用
下载
收藏
页码:1173 / 1179
页数:6
相关论文
共 50 条
  • [31] Successful treatment of steroid and cyclophosphamide-resistant diffuse scleroderma-associated interstitial lung disease with rituximab
    Wan-Hee Yoo
    Rheumatology International, 2012, 32 : 795 - 798
  • [32] Successful treatment of steroid and cyclophosphamide-resistant diffuse scleroderma-associated interstitial lung disease with rituximab
    Yoo, Wan-Hee
    RHEUMATOLOGY INTERNATIONAL, 2012, 32 (03) : 795 - 798
  • [33] Concomitant Acute Exacerbation Of Scleroderma-Associated Interstitial Lung Disease With Renal-Limited Anca-Associated Vasculitis
    Chartrand, S.
    Kern, E.
    Taryle, D. A.
    Fischer, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [34] VERIFICATION OF GENETIC ASSOCIATIONS WITH SCLERODERMA ASSOCIATED INTERSTITIAL LUNG DISEASE
    Stock, C. J. W.
    DeLauretis, A.
    Visca, D.
    Daccord, C.
    Kokosi, M.
    Kouranos, V.
    Margaritopoulos, G.
    George, P. M.
    Molyneaux, P. L.
    Chua, F.
    Maher, T. M.
    Abraham, D. J.
    Denton, C. P.
    Ong, V.
    Wells, A. U.
    Renzoni, E. A.
    THORAX, 2019, 74 : A46 - A46
  • [35] Microarray profiling reveals suppressed interferon stimulated gene program in fibroblasts from scleroderma-associated interstitial lung disease
    Gisela E Lindahl
    Carmel JW Stock
    Xu Shi-Wen
    Patricia Leoni
    Piersante Sestini
    Sarah L Howat
    George Bou-Gharios
    Andrew G Nicholson
    Christopher P Denton
    Jan C Grutters
    Toby M Maher
    Athol U Wells
    David J Abraham
    Elisabetta A Renzoni
    Respiratory Research, 14
  • [36] Microarray profiling reveals suppressed interferon stimulated gene program in fibroblasts from scleroderma-associated interstitial lung disease
    Lindahl, Gisela E.
    Stock, Carmel J. W.
    Xu Shi-Wen
    Leoni, Patricia
    Sestini, Piersante
    Howat, Sarah L.
    Bou-Gharios, George
    Nicholson, Andrew G.
    Denton, Christopher P.
    Grutters, Jan C.
    Maher, Toby M.
    Wells, Athol U.
    Abraham, David J.
    Renzoni, Elisabetta A.
    RESPIRATORY RESEARCH, 2013, 14
  • [37] Gene expression meta-analysis reveals aging and cellular senescence signatures in scleroderma-associated interstitial lung disease
    Yang, Monica M.
    Lee, Seoyeon
    Neely, Jessica
    Hinchcliff, Monique
    Wolters, Paul J.
    Sirota, Marina
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [38] Gene Expression Meta-Analysis Reveals Aging and Cellular Senescence Signatures in Scleroderma-associated Interstitial Lung Disease
    Yang, Monica
    Lee, Seoyeon
    Neely, Jessica
    Sirota, Marina
    Wolters, Paul
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 3048 - 3049
  • [39] Asymptomatic pericardial disease in scleroderma-associated progressive interstitial lung disease and its relationship to pulmonary hypertension.
    Fischer, A
    Meehan, RT
    Ulrich, SK
    Curran-Everett, D
    Brown, KK
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S170 - S170
  • [40] Gastro-oesophageal dismotility measurements in scleroderma-associated interstitial lung disease: Correlation with respiratory and reflux symptoms
    De lauretis, Angelo
    Visca, Dina
    Ward, Simon
    Clayman, Claudia
    Murray, Charles
    Voon, Ong
    Denton, Christopher
    Lindahl, Gisela
    Stock, Carmel
    Chetta, Alfredo
    Aiello, Marina
    Alfieri, Veronica
    Kreuter, Michael
    Wuyts, Wim
    Maher, Toby
    Wells, Athol U.
    Renzoni, Elisabetta
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46